Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
about
Signalling through CD30 protects against autoimmune diabetes mediated by CD8 T cellsCharacterization of a new family of proteins that interact with the C-terminal region of the chromatin-remodeling factor CHD-3Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activationCD30: from basic research to cancer therapyPleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) familyCD27-CD70 interaction: unravelling its implication in normal and neoplastic B-cell growthPrimary mediastinal B-cell lymphoma: treatment and therapeutic targetsCD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteinsMolecular characterization of a novel intracellular hyaluronan-binding proteinA mass spectrometric-derived cell surface protein atlasDiagnostic, prognostic and therapeutic role of CD30 in lymphoma.CD30 prevents T-cell responses to non-lymphoid tissues.Historical review of lymphomas.Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologueA simple guide to the terminology and application of leucocyte monoclonal antibodies.Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.Ki-1/57 interacts with RACK1 and is a substrate for the phosphorylation by phorbol 12-myristate 13-acetate-activated protein kinase C.The role of CD30 in atopic disease.Anaplastic large cell lymphoma: pathological, molecular and clinical features.Translocations involving anaplastic lymphoma kinase (ALK).Persistent atypical lymphocytic hyperplasia following tick bite in a child: report of a case and review of the literature.Hypomethylation of CD30 CpG islands with aberrant JunB expression drives CD30 induction in Hodgkin lymphoma and anaplastic large cell lymphoma.Identification of novel genes associated with renal tertiary lymphoid organ formation in aging mice.Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material.CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.Inhibition of type 1 cytokine-mediated inflammation by a soluble CD30 homologue encoded by ectromelia (mousepox) virus.Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnanciesPathobiology of classical Hodgkin lymphoma.Hodgkin's disease in northern Sweden 1971-1981. I. A histopathological reevaluation of 223 cases.Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.CD30: an important new target in hematologic malignancies.Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate.CD30 as a therapeutic target for lymphoma.Novel therapies for cutaneous T-cell lymphoma: what does the future hold?Role of CD30 targeting in malignant lymphoma.Emerging drugs for T-cell lymphoma.Antibodies and antibody-drug conjugates in the treatment of Hodgkin lymphoma.Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas.
P2860
Q22009150-E2677D8F-D1F0-465C-BEC9-34E53154B680Q24337828-43DE2EBC-7BBD-4B70-9A67-1F8AAC311B1FQ24679579-7F8DD6A1-C197-4C7B-97C1-D2CF281EC1D4Q26859079-EC5CC0B0-C3DC-4B5C-BD9E-90EDE2AFEC40Q28208696-CE3C45B0-1C74-4CBA-BD37-B01A1BEF15BEQ28274504-6BC3AF31-FCB9-440C-93C3-71DCA8155BFCQ28278652-48C593D4-528D-4190-A0BE-383113917AB4Q28281794-BAB3FE0F-4C68-475D-9893-3E2BBBA0E72CQ28504519-5413AEA6-0C8C-4900-8952-78B52DABA6D5Q28546580-63BA3AD0-7206-4009-B7A9-564462206A09Q30240160-D1003A08-8D78-43FF-8CF7-78E92B957E19Q33713263-C7895805-A25E-4791-9896-114A3187D6BFQ33962044-2B298B24-0D37-4039-AA70-1BA3024939CEQ34032643-005F88F1-08E4-411A-AA86-668AD1D18812Q34172760-312DAC3C-A0EB-4369-AECC-2BE366D0B355Q34194246-7944FB5B-A7FC-47EE-9A4B-5275FC33F3A8Q34286845-FD14BBF9-4197-4D6D-B6A1-729DCF073FF9Q34291177-C784C382-6C65-4BC7-8B05-6D52248D88EEQ34374218-08539C65-8AA6-4A5A-B075-F460A59AAAF4Q34405439-20F046D7-7B20-4A0B-9D4A-3A9694EBABD0Q34527841-8B137330-196C-43FE-AF34-24CB8682752EQ34707404-23207DA8-2C6B-483B-84F8-0F9D049B4ADCQ35122971-1CCF3A3B-829A-45D4-99CA-241F2982F273Q35239255-BEA0CB89-DE0B-489F-A037-564176C799DAQ36367932-13F26349-0A72-42A8-BDCD-01F3751174CBQ36371279-C4ED0180-C68A-4818-89C5-D154FE6CD894Q36500552-8613A60D-2440-40F6-A07F-C83F0BB7792AQ36512063-4715EDC8-0DCD-4113-8E33-763DBCC7CDBFQ36645613-D6AF7197-04C3-41F8-BBAA-33C3B93642B5Q37300546-4EFE1AD3-BBCF-487A-A138-FEAFA2C19309Q37461346-33F55B95-8F28-4D7A-8915-B9F580A70D0EQ37852758-35A32773-0879-492C-BD6F-D958FD0F0932Q37880873-06F93B7E-2232-471D-B4F8-FF159D70D614Q38073207-3F4084CB-F99E-45C1-9AEF-5D54997DE0EFQ38138482-F5A653AF-7802-4825-9F0E-7A115485FE0BQ38176398-1940241A-7C9B-40CC-87D0-4B05F4D33F7FQ38191191-92DC5004-D2EB-4B1A-A0CB-39ADA51D73C9Q38196943-214240A0-4767-442C-9732-988C0FE2E9E3Q38205923-D68992C2-5786-496A-832E-CA3CEF94890EQ38307616-09C4195A-69BC-4CF7-8D17-DFC5B10D6D20
P2860
Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature у вересні 1982
@uk
name
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@en
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@nl
type
label
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@en
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@nl
prefLabel
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@en
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@nl
P2093
P356
P1433
P1476
Production of a monoclonal ant ...... ubset of normal lymphoid cells
@en
P2093
H Kirchner
P2860
P2888
P356
10.1038/299065A0
P407
P577
1982-09-01T00:00:00Z
P6179
1023227919